SCHEMBL6154340

SCHEMBL6154340

CCCCCCCCCC(CCCCC)OC(=O)NCc1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.50
POLB P06746 1/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 1/20 0.45
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155335 0.88 TLR2 (0.52) CTSKHPGDHSD17B10SMN1; SMN2CYP1A2
SCHEMBL26555049 0.84 CTSK (0.46) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL26555058 0.82 CTSK (0.46) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL6154861 0.81 TLR2 (0.45) CTSKHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL6154733 0.81 EPHX2 (0.57) CTSK
SCHEMBL26555052 0.81 CTSK (0.45) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL10290433 0.79 HPGD (0.55) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL12206721 0.79 SMN1; SMN2 (0.61) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL12352407 0.79 SMN1; SMN2 (0.64) CTSKHPGDHSD17B10SMN1; SMN2POLB
SCHEMBL6155149 0.79 LMNA (0.52) CTSKSMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499326-A1 OXOLIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-01-26 EP claimed
WO-2003090760-A1 OXOLIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO claimed
EP-1499326-A1 OXOLIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-01-26 EP disclosed
WO-2003090760-A1 OXOLIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO disclosed